Reproducibility of a Digital Twin of Canagliflozin Pharmacokinetics and Pharmacodynamics in Type 2 Diabetes Mellitus
Elias M, Myshkina M, Tereshchuk V, and König M · Physiome, 2026 · First Author
A Digital Twin of Canagliflozin Pharmacokinetics and Pharmacodynamics in Type 2 Diabetes Mellitus
Tereshchuk V, Elias M, and König M · Preprints, 2026 · Co-Author
Rivaroxaban Pharmacokinetics and Coagulation Effects: Reproducibility of a Physiologically Based Modeling Approach
Myshkina M, Elias M, Casabianca E, and König M · Physiome, 2026 · Second Author
Reproducibility of a Digital Twin of the Angiotensin II Receptor Blocker Losartan
Myshkina M, Elias M, Tensil E, and König M · Physiome, 2026 · Second Author
Reproducibility of a Physiologically Based Pharmacokinetic and Pharmacodynamic (PBPK/PD) Model of Dapagliflozin
Elias M, Myshkina M, Nemitz N, and König M · Physiome, 2026 · First Author
A Physiologically Based Pharmacokinetic and Pharmacodynamic (PBPK/PD) Model of Dapagliflozin in Type 2 Diabetes Mellitus: The Effect of Dosing, Hepatorenal Impairment, and Food
Nemitz N, Elias M, and König M · Pharmaceutics, 2026 · Co-Author
Reproducibility of a Digital Twin of Glimepiride for Personalized and Stratified Diabetes Treatment
Elias M and König M · Physiome, 2025 · First Author
A digital twin of glimepiride for personalized and stratified diabetes treatment
Elias M and König M · Frontiers in Pharmacology, 2025 · First Author